Literature DB >> 22442002

The effects of angiotensin peptides and angiotensin receptor antagonists on the cell growth and angiogenic activity of GH3 lactosomatotroph cells in vitro.

Dorota Ptasinska-Wnuk1, Slawomir A Mucha, Hanna Lawnicka, Jolanta Fryczak, Jolanta Kunert-Radek, Marek Pawlikowski, Henryk Stepien.   

Abstract

The local renin-angiotensin system (RAS) is present in the pituitary gland, and inhibitory effects of angiotensins on the lactosomatotroph (GH3) cell growth have been revealed. The aim of this study was to examine the influence of various angiotensin peptides and angiotensin AT1, AT2, and AT4 receptors antagonists on the cell proliferation, viability, and VEGF secretion in pituitary lactosomatotroph GH3 cell culture in order to identify receptors involved in antiproliferative effects of angiotensins on GH3 tumor cells. Cell viability and proliferation using Mosmann method and BrdU incorporation during DNA synthesis, and VEGF secretion using ELISA assay were estimated. The inhibitory effects of ang II, ang IV, and ang 5-8 on the cell viability and BrdU incorporation in GH3 culture were not abolished by AT1, AT2, and AT4 receptors antagonists. Ang II, as well as ang III and ang IV at lower concentrations stimulated the secretion of VEGF in GH3 cell culture. The secretion of VEGF was inhibited by ang III and ang IV at higher concentrations. AT1 and AT2 receptors antagonists prevented the proangiogenic effects of ang II. Ang II, ang IV, and ang 5-8 decrease the cell number and proliferation in GH3 cell culture independently of the AT1, AT2, and AT4 receptors. These peptides affect also secretion of VEGF in culture examined. Both the AT1 and AT2 receptors appear to mediate the proangiogenic effects of ang II.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22442002     DOI: 10.1007/s12020-012-9659-2

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  55 in total

1.  Secretion of renin-angiotensin system (RAS) components by normal and tumoral lactotropes. A comparative study using reverse hemolytic plaque assay (RHPA) and immunoelectron microscopy.

Authors:  E Vila-Porcile; A Barret; P Corvol
Journal:  J Histochem Cytochem       Date:  2000-12       Impact factor: 2.479

2.  The involvement of the renin-angiotensin system in the regulation of cell proliferation in the rat endometrium.

Authors:  M Pawlikowski; G Meleń-Mucha; S Mucha
Journal:  Cell Mol Life Sci       Date:  1999-03       Impact factor: 9.261

3.  Enhanced angiotensin-converting enzyme 2 attenuates angiotensin II-induced collagen production via AT1 receptor-phosphoinositide 3-kinase-Akt pathway.

Authors:  Le Bu; Shen Qu; Xiang Gao; J-J Zou; Wei Tang; L-L Sun; Z-M Liu
Journal:  Endocrine       Date:  2010-12-28       Impact factor: 3.633

4.  Sequential development of angiotensin receptors and angiotensin I converting enzyme during angiogenesis in the rat subcutaneous sponge granuloma.

Authors:  D A Walsh; D E Hu; J Wharton; J D Catravas; D R Blake; T P Fan
Journal:  Br J Pharmacol       Date:  1997-04       Impact factor: 8.739

5.  Localization of vascular endothelial growth factor (VEGF) receptors in normal and adenomatous pituitaries: detection of a non-endothelial function of VEGF in pituitary tumours.

Authors:  Chiara Onofri; Marily Theodoropoulou; Marco Losa; Eberhard Uhl; Manfred Lange; Eduardo Arzt; Günter K Stalla; Ulrich Renner
Journal:  J Endocrinol       Date:  2006-10       Impact factor: 4.286

6.  Biphasic estrogen response on bovine adrenal medulla capillary endothelial cell adhesion, proliferation and tube formation.

Authors:  S K Banerjee; D R Campbell; A P Weston; D K Banerjee
Journal:  Mol Cell Biochem       Date:  1997-12       Impact factor: 3.396

7.  Angiotensin IV stimulates the activity of tyrosine kinases in rat anterior pituitary gland acting via AT1-like receptors?

Authors:  E Rebas; A Lachowicz-Ochedalska; M Pawlikowski
Journal:  J Physiol Pharmacol       Date:  2004-03       Impact factor: 3.011

8.  Identification of endocrine cell populations expressing the AT1B subtype of angiotensin II receptors in the anterior pituitary.

Authors:  Z Lenkei; A M Nuyt; D Grouselle; P Corvol; C Llorens-Cortès
Journal:  Endocrinology       Date:  1999-01       Impact factor: 4.736

9.  Pasireotide, a multiple somatostatin receptor subtypes ligand, reduces cell viability in non-functioning pituitary adenomas by inhibiting vascular endothelial growth factor secretion.

Authors:  Maria Chiara Zatelli; Daniela Piccin; Cristina Vignali; Federico Tagliati; Maria Rosaria Ambrosio; Marta Bondanelli; Vincenzo Cimino; Antonio Bianchi; Herbert A Schmid; Massimo Scanarini; Alfredo Pontecorvi; Laura De Marinis; Giulio Maira; Ettore C degli Uberti
Journal:  Endocr Relat Cancer       Date:  2007-03       Impact factor: 5.678

10.  Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells.

Authors:  B Williams; A Q Baker; B Gallacher; D Lodwick
Journal:  Hypertension       Date:  1995-05       Impact factor: 10.190

View more
  2 in total

1.  Comparative effects of angiotensin II and angiotensin-(4-8) on blood pressure and ANP secretion in rats.

Authors:  Hoang Thi Ai Phuong; Lamei Yu; Byung Mun Park; Suhn Hee Kim
Journal:  Korean J Physiol Pharmacol       Date:  2017-10-30       Impact factor: 2.016

2.  The Evidence for Sparsentan-Mediated Inhibition of INa and IK(erg): Possibly Unlinked to Its Antagonism of Angiotensin II or Endothelin Type a Receptor.

Authors:  Tzu-Hsien Chuang; Hsin-Yen Cho; Sheng-Nan Wu
Journal:  Biomedicines       Date:  2021-12-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.